tiprankstipranks
PEPTONIC medical AB (DE:28L)
FRANKFURT:28L
Germany Market

PEPTONIC medical AB (28L) Financial Statements

0 Followers

PEPTONIC medical AB Financial Overview

PEPTONIC medical AB's market cap is currently €2.97M. The company's EPS TTM is $0; its P/E ratio is ―; PEPTONIC medical AB is scheduled to report earnings on August 19, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19Dec 18Dec 17
Income Statement
Total Revenue
Gross Profit$ 19.07M$ 13.09M$ 2.56M$ 232.31K$ 75.67K
Operating Income$ -73.72M$ -31.05M$ -23.92M$ -14.38M$ -12.96M
EBITDA$ -46.56M$ -27.77M$ -21.02M$ -14.29M$ -12.84M
Net Income$ -73.69M$ -31.09M$ -24.51M$ -14.94M$ -12.97M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 83.50M$ 134.44M$ 91.95M$ 69.16M$ 65.38M
Total Debt$ 0.00$ 0.00$ 39.64K$ 10.50M$ 63.41K
Net Debt$ -10.15M$ -39.31M$ -35.94M$ -865.07K$ -6.99M
Total Liabilities$ 31.48M$ 16.62M$ 6.24M$ 13.91M$ 5.69M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -44.62M$ -48.68M$ -19.85M$ -16.69M$ -16.14M
Operating Cash Flow$ -40.34M$ -45.86M$ -19.14M$ -16.11M$ -11.37M
Investing Cash Flow
Financing Cash Flow

PEPTONIC medical AB Earnings and Revenue History

PEPTONIC medical AB Debt to Assets

PEPTONIC medical AB Cash Flow

PEPTONIC medical AB Forecast EPS vs Actual EPS